iRNA AGENTS WITH BIOCLEAVABLE TETHERS
AssigneeAlnylam Pharmaceuticals, Inc.
InventorsMuthiah MANOHARAN, Kallanthottathil G. RAJEEV
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlnylam Pharmaceuticals, Inc.
InventorsMuthiah MANOHARAN, Kallanthottathil G. RAJEEV
Estimating the term…
The invention relates to iRNA agents, which preferably include a monomer in which the ribose moiety has been replaced by a moiety other than ribose that further includes a tether having one or more linking groups, in which at least one of the linking groups is a cleavable linking group. The tether in turn can be connected to a selected moiety, e.g., a ligand, e.g., a targeting or delivery moiety, or a moiety which alters a physical property. The cleavable linking group is one which is sufficiently stable outside the cell such that it allows targeting of a therapeutically beneficial amount of an iRNA agent (e.g., a single stranded or double stranded iRNA agent), coupled by way of the cleavable linking group to a targeting agent—to targets cells, but which upon entry into a target cell is cleaved to release the iRNA agent from the targeting agent.
An iRNA agent comprising a first strand and optionally a second strand, wherein at least one subunit having a formula (I) is incorporated into at least one of the strands:
Dependencies are inferred from the claim text.